10206
T2D patients are routinely treated with oral antidiabetic agents such as sulfonylureas or dipeptidyl peptidase - 4 antagonists , which promote glucose - and incretin - dependent insulin secretion , respectively .
 Chemical: sulfonylureas; Chemical: glucose
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 Chemical: sulfonylureas; Chemical: glucose